Citations (9)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Yu-Ting Lin, Tamara Will, Charlotte Wickham, Petra Boeree, Dominic Jack & Matthew Keiser. (2023) Evolution of the RebiSmart® Electromechanical Autoinjector to Improve Usability in Support of Adherence to Subcutaneous Interferon Beta-1a Therapy for People Living with Multiple Sclerosis. Patient Preference and Adherence 17, pages 1923-1933.
Read now
Read now
Martin Vališ, Jana Šarláková, Simona Halúsková, Blanka Klímová, Pavel Potužník, Marek Peterka, Kamil Kuča, Pavel Štourač, Jan Mareš & Zbyšek Pavelek. (2020) An observational study demonstrating the adherence and ease of use of the injector device, RebiSmart®. Expert Opinion on Drug Delivery 17:5, pages 719-724.
Read now
Read now
Beate Bittner, Chantal Schmit Chiesi, Saifuddin Kharawala, Gavneet Kaur & Johannes Schmidt. (2019) Connected drug delivery devices to complement drug treatments: potential to facilitate disease management in home setting. Medical Devices: Evidence and Research 12, pages 101-127.
Read now
Read now
Articles from other publishers (6)
Ryan Farej, Mark Rametta, Anneliese La Rose, Apryl Quillen & Kim McLeod. (2022) A Prospective, Observational, Multicenter Study Assessing Adherence to Interferon Beta-1b Therapy and Patient Satisfaction Using the BETACONNECT Auto-Injector. Neurology and Therapy 11:1, pages 373-384.
Crossref
Crossref
Joshua MardanMohammad Akhtar HussainMichelle AllanLisa B Grech. (2021) Objective medication adherence and persistence in people with multiple sclerosis: a systematic review, meta-analysis, and meta-regression. Journal of Managed Care & Specialty Pharmacy 27:9, pages 1273-1295.
Crossref
Crossref
Diego Centonze, Roberta Fantozzi, Fabio Buttari, Luigi Maria Edoardo Grimaldi, Rocco Totaro, Francesco Corea, Maria Giovanna Marrosu, Paolo Confalonieri, Salvatore Cottone, Maria Trojano & Valentina Zipoli. (2021) Multicenter Interventional Phase IV Study for the Assessment of the Effects on Patient's Satisfaction of Peg IFN Beta-1a (Pre-filled Pen) in Subjects With Relapsing–Remitting Multiple Sclerosis Unsatisfied With Other Injectable Subcutaneous Interferons (PLATINUM Study). Frontiers in Neurology 12.
Crossref
Crossref
A. Blanco-López, C. Antillón-Ferreira, E. Saavedra-Castillo, M. Barrientos-Pérez, H. Rivero-Escalante, O. Flores-Caloca, R. Calzada-León, C. C. Rosas-Guerra, E. Koledova, E. Chiquete & A. Ayala-Estrada. (2020) Adherence to treatment in children with growth hormone deficiency, small for gestational age and Turner syndrome in Mexico: results of the Easypod™ connect observational study (ECOS). Journal of Endocrinological Investigation 43:10, pages 1447-1452.
Crossref
Crossref
Sergio Sauri-Suárez, Sandra Quiñones-Aguilar, Arturo Contreras-Marín, Erik Omar Ramiro-Guerrero, David Zúñiga-García, Leticia Salinas-Vázquez, Leonardo Llamas-López, Carolina León-Jiménez, Adriana García-Martell, Iliana González-Hernández, Erwin Chiquete & Silvia García. (2020) Adherence to self-administering interferon-β1a using RebiSmart® device in Mexican patients with relapsing multiple sclerosis. PLOS ONE 15:4, pages e0230959.
Crossref
Crossref
. (2018) Interferon-β-1a. Reactions Weekly 1705:1, pages 168-168.
Crossref
Crossref